Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Net sales $ 3,577,778 $ 1,461,428
Cost of sales 2,776,685 1,023,911
Gross profit 801,093 437,517
Operating expenses:    
Selling, general and administrative 574,350 175,890
Salaries, wages and payroll taxes 635,576 208,174
Professional fees 326,213 278,682
Depreciation and amortization 99,569 73,700
Total operating expenses 1,635,708 736,446
(Loss) before other expenses and income taxes (834,615) (298,929)
Interest expense 3,243 520,694
Interest earned (4,956)
Foreign currency exchange rate variance 17,181 (16,481)
Total other income 15,468 504,213
Net loss (850,083) (803,142)
Comprehensive (loss) income:    
Net loss (850,083) (803,142)
Foreign currency translation adjustments (15,330) 1,611
Comprehensive loss $ (865,413) $ (801,531)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS    
Weighted number of common shares outstanding – basic & diluted 9,166,877 985,235
Basic and diluted net (loss) per share $ (0.09) $ (0.82)